SCHEMBL847441

SCHEMBL847441

CC1(C(=O)NCc2ccccc2)COC(=O)OC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.52
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.50
MAPT P10636 1/20 0.49
MMP8 P22894 1/20 0.49
HPGD P15428 3/20 0.48
LMNA P02545 1/20 0.46
PTPN1 P18031 1/20 0.46
METAP2 P50579 1/20 0.45
HTT P42858 1/20 0.44
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
NR3C2 P08235 1/20 0.43
EPHX1 P07099 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
SLC6A4 P31645 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10262393 0.84 TSHR (0.44) TSHRMEN1KMT2AL3MBTL1SMN1; SMN2
SCHEMBL28443894 0.84 SMN1; SMN2 (0.51) TSHRMEN1KMT2AL3MBTL1SMN1; SMN2
SCHEMBL13575063 0.80 ALDH1A1 (0.55) TSHRKMT2AHPGDLMNAHTT
SCHEMBL20848664 0.78 TSHR (0.39) TSHRMEN1KMT2AL3MBTL1SMN1; SMN2
SCHEMBL1525284 0.77 SMN1; SMN2 (0.54) TSHRMEN1KMT2AL3MBTL1SMN1; SMN2
SCHEMBL1300684 0.77 TSHR (0.43) TSHRMEN1KMT2AL3MBTL1SMN1; SMN2
SCHEMBL19124738 0.75 KMT2A (0.43) MEN1KMT2ASMN1; SMN2MAPTLMNA
SCHEMBL21077981 0.75 SMN1; SMN2 (0.51) TSHRMEN1KMT2AL3MBTL1SMN1; SMN2
SCHEMBL16565171 0.73 METAP2 (0.51) TSHRMEN1KMT2AL3MBTL1SMN1; SMN2
SCHEMBL20150450 0.73 POLB (0.47) MEN1KMT2ASMN1; SMN2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 229 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11690380-B2 Antimicrobial guanidinium and thiouronium functionalized polymers CORAL BAY II, LLC (US) 2023-07-04 US disclosed
US-11690380-B2 Antimicrobial guanidinium and thiouronium functionalized polymers CORAL BAY II, LLC (US) 2023-07-04 US disclosed
US-11180608-B2 Biodegradable polymers, complexes thereof for gene therapeutics and drug delivery, and methods related thereto INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2021-11-23 US disclosed
US-11149114-B2 Biodegradable polymers, complexes thereof for gene therapeutics and drug delivery, and methods related thereto INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2021-10-19 US disclosed
US-10980234-B2 Antimicrobial guanidinium and thiouronium functionalized polymers CORAL BAY II, LLC (US) 2021-04-20 US disclosed
US-10779539-B2 Antimicrobial guanidinium and thiouronium functionalized polymers CORAL BAY II, LLC. (US) 2020-09-22 US disclosed
EP-3259292-B1 BLOCK COPOLYMERS WITH SURFACE-ACTIVE JUNCTION GROUPS, COMPOSITIONS AND PROCESSES THEREOF AZ ELECTRONIC MAT LUXEMBOURG SARL (LU) 2020-04-08 EP disclosed
US-10610597-B2 Polycarbonates bearing aromatic N-heterocycles for drug delivery INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2020-04-07 US disclosed
US-10457759-B2 Co-delivery of cholesterol lowering drugs and nutraceuticals INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2019-10-29 US disclosed
EP-2516502-B1 BIODEGRADABLE BLOCK POLYMERS FOR DRUG DELIVERY, AND METHODS RELATED THERETO IBM (US) 2019-05-15 EP disclosed
WO-2011078804-A1 ANTIMICROBIAL POLYMERS AND METHODS OF MANUFACTURE THEREOF INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2011-06-30 WO disclosed
WO-2011078803-A1 BIODEGRADABLE BLOCK POLYMERS FOR DRUG DELIVERY, AND METHODS RELATED THERETO INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2011-06-30 WO disclosed
US-20110150977-A1 ANTIMICROBIAL POLYMERS AND METHODS OF MANUFACTURE THEREOF AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2011-06-23 US disclosed
US-20110151566-A1 BIODEGRADABLE POLYMERS, COMPLEXES THEREOF FOR GENE THERAPEUTICS AND DRUG DELIVERY, AND METHODS RELATED THERETO AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2011-06-23 US disclosed
US-20110151566-A1 BIODEGRADABLE POLYMERS, COMPLEXES THEREOF FOR GENE THERAPEUTICS AND DRUG DELIVERY, AND METHODS RELATED THERETO AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2011-06-23 US disclosed
US-20110152167-A1 BIODEGRADABLE BLOCK POLYMERS FOR DRUG DELIVERY, AND METHODS RELATED THERETO AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2011-06-23 US disclosed
US-20110152167-A1 BIODEGRADABLE BLOCK POLYMERS FOR DRUG DELIVERY, AND METHODS RELATED THERETO AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2011-06-23 US disclosed
US-20110150977-A1 ANTIMICROBIAL POLYMERS AND METHODS OF MANUFACTURE THEREOF AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2011-06-23 US disclosed
US-20100305281-A1 POLYMERS BEARING PENDANT PENTAFLUOROPHENYL ESTER GROUPS, AND METHODS OF SYNTHESIS AND FUNCTIONALIZATION THEREOF INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2010-12-02 US disclosed
US-20100305281-A1 POLYMERS BEARING PENDANT PENTAFLUOROPHENYL ESTER GROUPS, AND METHODS OF SYNTHESIS AND FUNCTIONALIZATION THEREOF INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11149114-B2 Biodegradable polymers, complexes thereof for gene therapeutics and drug delivery, and methods related thereto DCLRE1A, ODC1, MRTO4 TSHR 4384/4885MEN1 3087/4885KMT2A 1645/4885
US-11180608-B2 Biodegradable polymers, complexes thereof for gene therapeutics and drug delivery, and methods related thereto DCLRE1A, ODC1, MRTO4 TSHR 4384/4885MEN1 3087/4885KMT2A 1645/4885
US-10980234-B2 Antimicrobial guanidinium and thiouronium functionalized polymers PUF60, CAPG, GMPS TSHR 1864/4885MEN1 2821/4885KMT2A 4588/4885
US-10457759-B2 Co-delivery of cholesterol lowering drugs and nutraceuticals STARD3, HMGCR, CETP TSHR 4338/4885MEN1 4236/4885KMT2A 3617/4885
US-11690380-B2 Antimicrobial guanidinium and thiouronium functionalized polymers PUF60, CAPG, GMPS TSHR 1864/4885MEN1 2821/4885KMT2A 4588/4885
US-20110150977-A1 ANTIMICROBIAL POLYMERS AND METHODS OF MANUFACTURE THEREOF MLEC, NOD2, PAM TSHR 4155/4885MEN1 3094/4885KMT2A 3066/4885
US-20100305281-A1 POLYMERS BEARING PENDANT PENTAFLUOROPHENYL ESTER GROUPS, AND METHODS OF SYNTHESIS AND FUNCTIONALIZATION THEREOF PFAS, PAM, PCNA TSHR 1728/4885MEN1 2426/4885KMT2A 4165/4885
US-10779539-B2 Antimicrobial guanidinium and thiouronium functionalized polymers PUF60, CAPG, GMPS TSHR 1864/4885MEN1 2821/4885KMT2A 4588/4885
US-20110152167-A1 BIODEGRADABLE BLOCK POLYMERS FOR DRUG DELIVERY, AND METHODS RELATED THERETO SAMM50, ADRM1, UFM1 TSHR 1975/4885MEN1 3976/4885KMT2A 3339/4885
US-10610597-B2 Polycarbonates bearing aromatic N-heterocycles for drug delivery PAH, SULT1E1, SULT1A1 TSHR 4486/4885MEN1 3599/4885KMT2A 722/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.